CytoSorbents, Converge Biotech announce strategic partnership

CytoSorbents (CTSO) and Converge Biotech announce a new strategic collaboration where the two companies seek to expand their combined market reach in the sepsis and critical care markets in India with a broad synergistic product portfolio. Converge Biotech will leverage its extensive critical care sales force and strong hospital network to accelerate CytoSorb’s market penetration in India, ensuring more healthcare facilities have access to this critical therapy. In doing so, CytoSorb will help Converge Biotech strengthen its existing intensive care unit portfolio to now include the treatment of sepsis and other life-threatening diseases.